This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,437.28 firm-fixed-price delivery order is for the supply of 100-unit vials of Botox, a specialty medication. The contract has an ultimate completion date of January 2, 2025 and was awarded on December 10, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a comprehensive vehicle for providing a range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.
Generated 3/11/25, 9:44 AM